Company intelligence / Profile preview

Aarden Pharmaceuticals

Indianapolis, Indiana, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Aarden was a small molecule drug discovery and development company focused on inhibiting protein tyrosine phosphatases, targeting diseases previously considered "undruggable." The company is no longer active.

Therapeutic areas: OncologyEndocrinologyImmunologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Indiana University School of Medicine (academic collaboration)

Beyond the preview

Go deeper on Aarden Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aarden Pharmaceuticals.

Explore the full profile